Patients with other MNDs had significantly higher plasma NFL levels than patients with neuropathies and myelopathies (p < 0.01), patients with myopathies (p < 0.05) and controls with no neurological disorder (p < 0.01) (Fig. 2E). The gene discussed is NEFL; the disease is Myelopathy.